Novocure Ltd.

06/21/2022 | Press release | Distributed by Public on 06/21/2022 06:07

Novocure Enrolls First Patient in KEYNOTE-B36, a Pilot Study of Tumor Treating Fields Together with KEYTRUDA® for Patients with First-Line Stage III Non-Small Cell Lung Cancer